ATLASMaravai LifeSciences (MRVI) earnings date: Nov 4, 2026
Maravai LifeSciences (MRVI) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$0.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MRVI
| Last price | $7.81 (-7.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Maravai LifeSciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Maravai LifeSciences reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Maravai LifeSciences. You can switch it off at any time.
Alert me before MRVI reportsFree to start. Creating an account takes under a minute.
MRVI earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.07 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 3 reports) | 3 of 3 (100%) |
| Average EPS surprise | +43.1% |
| Average move around a report | ±2.4% (last 3) |
| Sector | Healthcare · Biotechnology |
Maravai LifeSciences earnings history: last 3 reports
Maravai LifeSciences last reported on Aug 6, 2026: EPS of -$0.02 against an estimate of -$0.04 (+50.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.04 | -$0.02 | +50.0% | Beat | -2.8% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | -2.0% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | +2.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MRVI
See the fair value, the probability range and the earnings history of Maravai LifeSciences on its ATLAS page.
Maravai LifeSciences (MRVI) stock analysisPlans from €3.99 a month.
Maravai LifeSciences earnings: frequently asked questions
When does Maravai LifeSciences (MRVI) report earnings?
Maravai LifeSciences is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MRVI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.07 per share (USD). Estimates can change before the report.
How often does MRVI beat earnings estimates?
Of its last 3 reports with a recorded result, Maravai LifeSciences beat the EPS estimate 3 times; the average surprise was +43.1%. Past results do not predict the next one.
How much does MRVI move around earnings?
Over its last 3 reports the stock moved an average of 2.4% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Maravai LifeSciences beat earnings estimates last quarter?
Maravai LifeSciences last reported on Aug 6, 2026: EPS of -$0.02 against an estimate of -$0.04 (+50.0% surprise), a beat.
How much does MRVI usually move in a day?
On a normal trading day the ATLAS model puts MRVI’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer